Micelle-like nanoparticles as carriers for DNA and siRNA

Molecular Pharmaceutics

Volumn 12, Issue 2, 2015, Pages 301-313

  Navarro, Gemma ^a   Pan, Jiayi ^a   Torchilin, Vladimir P ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

cationic amphiphiles; cationic polymers; complexes; DNA delivery; gene delivery; micelle like nanoparticles; siRNA delivery

Indexed keywords

AMPHOPHILE; CHITOSAN; CHOLESTEROL; COPOLYMER; DENDRIMER; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DNA; DOXORUBICIN; MACROGOL; MICELLE LIKE NANOPARTICLE; NANOCARRIER; PENETRATION ENHANCING AGENT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYAMIDOAMINE; POLYCAPROLACTONE; POLYETHYLENEIMINE; POLYLYSINE; QUANTUM DOT; SATURATED FATTY ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VASCULOTROPIN; DRUG CARRIER; MICELLE; NANOPARTICLE;

CATALYSIS; CELL MEMBRANE; COMPUTER SIMULATION; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG PENETRATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HYDROPHOBICITY; INTERNALIZATION; LIGHT; MAGNETIC FIELD; MEMBRANE PERMEABILITY; MICELLE; MOLECULAR IMAGING; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; TEMPERATURE; ANIMAL; CHEMISTRY;

ANIMALS; DNA; DRUG CARRIERS; HUMANS; MICELLES; NANOPARTICLES; RNA, SMALL INTERFERING;

EID: 84922189120     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5007213     Document Type: Review

References (159)

1. Anderson, W. F.; Blaese, R. M.; Culver, K. The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990 Hum. Gene Ther. 1990, 1 (3) 331-62
2. Ginn, S. L.; Alexander, I. E.; Edelstein, M. L.; Abedi, M. R.; Wixon, J. Gene therapy clinical trials worldwide to 2012-an update J. Gene Med. 2013, 15 (2) 65-77
3. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144 (5) 646-74
4. Patel, N. R.; Pattni, B. S.; Abouzeid, A. H.; Torchilin, V. P. Nanopreparations to overcome multidrug resistance in cancer Adv. Drug Delivery Rev. 2013, 65 (13-14) 1748-62
5. Nakamura, K.; Abu Lila, A. S.; Matsunaga, M.; Doi, Y.; Ishida, T.; Kiwada, H. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA Mol. Ther. 2011, 19 (11) 2040-7
6. Kang, S. H.; Cho, H. J.; Shim, G.; Lee, S.; Kim, S. H.; Choi, H. G.; Kim, C. W.; Oh, Y. K. Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy Pharm. Res. 2011, 28 (12) 3069-78
7. Salzano, G.; Riehle, R.; Navarro, G.; Perche, F.; De Rosa, G.; Torchilin, V. P. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer Cancer Lett. 2014, 343 (2) 224-31
8. Su, B.; Cengizeroglu, A.; Farkasova, K.; Viola, J. R.; Anton, M.; Ellwart, J. W.; Haase, R.; Wagner, E.; Ogris, M. Systemic TNFalpha gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer Mol. Ther. 2013, 21 (2) 300-8
9. Xu, Q.; Xia, Y.; Wang, C. H.; Pack, D. W. Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy J. Controlled Release 2012, 163 (2) 130-5
10. Baguley, B. C., Multidrug Resistance in Cancer. In Multi-Drug Resistance in Cancer; Zhou, J., Ed.; Humana Press: 2010; Vol. 596, pp 1-14.
11. Chen, H.; Hao, J.; Wang, L.; Li, Y. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression Br. J. Cancer 2009, 101 (3) 432-40
12. Lee, T. B.; Park, J. H.; Min, Y. D.; Kim, K. J.; Choi, C. H. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy BMC Gastroenterol. 2008, 8, 33
13. Leonessa, F.; Clarke, R. ATP binding cassette transporters and drug resistance in breast cancer Endocr.-Relat. Cancer 2003, 10 (1) 43-73
14. Abbasi, M.; Lavasanifar, A.; Berthiaume, L. G.; Weinfeld, M.; Uludag, H. Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells Cancer 2010, 116 (23) 5544-54
15. Liu, C.; Zhao, G.; Liu, J.; Ma, N.; Chivukula, P.; Perelman, L.; Okada, K.; Chen, Z.; Gough, D.; Yu, L. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel J. Controlled Release 2009, 140 (3) 277-83
16. Peng, Z.; Xiao, Z.; Wang, Y.; Liu, P.; Cai, Y.; Lu, S.; Feng, W.; Han, Z. C. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells Cancer Gene Ther. 2004, 11 (11) 707-12
17. Yadav, S.; van Vlerken, L. E.; Little, S. R.; Amiji, M. M. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells Cancer Chemother. Pharmacol. 2009, 63 (4) 711-22
18. Tsouris, V.; Joo, M. K.; Kim, S. H.; Kwon, I. C.; Won, Y. Y. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers Biotechnol. Adv. 2014, 32 (5) 1037-50
19. Davidson, B. L.; McCray, P. B., Jr. Current prospects for RNA interference-based therapies Nat. Rev. Genet. 2011, 12 (5) 329-40
20. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; John, M.; Kesavan, V.; Lavine, G.; Pandey, R. K.; Racie, T.; Rajeev, K. G.; Rohl, I.; Toudjarska, I.; Wang, G.; Wuschko, S.; Bumcrot, D.; Koteliansky, V.; Limmer, S.; Manoharan, M.; Vornlocher, H. P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 2004, 432 (7014) 173-8
21. Malek, A.; Merkel, O.; Fink, L.; Czubayko, F.; Kissel, T.; Aigner, A. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes Toxicol. Appl. Pharmacol. 2009, 236 (1) 97-108
22. Gao, S.; Dagnaes-Hansen, F.; Nielsen, E. J.; Wengel, J.; Besenbacher, F.; Howard, K. A.; Kjems, J. The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice Mol. Ther. 2009, 17 (7) 1225-33
23. Kawabata, K.; Takakura, Y.; Hashida, M. The Fate of Plasmid DNA after Intravenous-Injection in Mice-Involvement of Scavenger Receptors in Its Hepatic-Uptake Pharm. Res. 1995, 12 (6) 825-830
24. Mellott, A. J.; Forrest, M. L.; Detamore, M. S. Physical non-viral gene delivery methods for tissue engineering Ann. Bio. Eng. 2013, 41 (3) 446-68
25. Giacca, M.; Zacchigna, S. Virus-mediated gene delivery for human gene therapy J. Controlled Release 2012, 161 (2) 377-88
26. Tros de Ilarduya, C.; Sun, Y.; Duzgunes, N. Gene delivery by lipoplexes and polyplexes Eur. J. Pharm. Sci. 2010, 40 (3) 159-70
27. Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S. Design and development of polymers for gene delivery Nat. Rev. Drug Discovery 2005, 4 (7) 581-93
28. Dufes, C.; Uchegbu, I. F.; Schatzlein, A. G. Dendrimers in gene delivery Adv. Drug Delivery Rev. 2005, 57 (15) 2177-202
29. Djurovic, S.; Iversen, N.; Jeansson, S.; Hoover, F.; Christensen, G. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes Mol. Biotechnol. 2004, 28 (1) 21-31
30. Kircheis, R.; Wightman, L.; Wagner, E. Design and gene delivery activity of modified polyethylenimines Adv. Drug Delivery Rev. 2001, 53 (3) 341-58
31. Morille, M.; Passirani, C.; Dufort, S.; Bastiat, G.; Pitard, B.; Coll, J. L.; Benoit, J. P. Tumor transfection after systemic injection of DNA lipid nanocapsules Biomaterials 2011, 32 (9) 2327-33
32. Ruponen, M.; Ronkko, S.; Honkakoski, P.; Pelkonen, J.; Tammi, M.; Urtti, A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes J. Biol. Chem. 2001, 276 (36) 33875-80
33. Lu, J. J.; Langer, R.; Chen, J. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery Mol. Pharmaceutics 2009, 6 (3) 763-71
34. Ballarin-Gonzalez, B.; Howard, K. A. Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions Adv. Drug Delivery Rev. 2012, 64 (15) 1717-29
35. Singh, S.; Narang, A. S.; Mahato, R. I. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA Pharm. Res. 2011, 28 (12) 2996-3015
36. Behr, J. P. The proton sponge: A trick to enter cells the viruses did not exploit Chimia 1997, 51 (1-2) 34-36
37. Won, Y. Y.; Sharma, R.; Konieczny, S. F. Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes J. Controlled Release 2009, 139 (2) 88-93
38. Yue, Y.; Jin, F.; Deng, R.; Cai, J.; Dai, Z.; Lin, M. C.; Kung, H. F.; Mattebjerg, M. A.; Andresen, T. L.; Wu, C. Revisit complexation between DNA and polyethylenimine - effect of length of free polycationic chains on gene transfection J. Controlled Release 2011, 152 (1) 143-51
39. Benjaminsen, R. V.; Mattebjerg, M. A.; Henriksen, J. R.; Moghimi, S. M.; Andresen, T. L. The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH Mol. Ther. 2013, 21 (1) 149-57
40. Lam, A. P.; Dean, D. A. Progress and prospects: nuclear import of nonviral vectors Gene Ther. 2010, 17 (4) 439-47
41. Grayson, A. C.; Doody, A. M.; Putnam, D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro Pharm. Res. 2006, 23 (8) 1868-76
42. Nishikawa, M.; Takemura, S.; Takakura, Y.; Hashida, M. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties J. Pharmacol. Exp. Ther. 1998, 287 (1) 408-15
43. Gebhart, C. L.; Kabanov, A. V. Evaluation of polyplexes as gene transfer agents J. Controlled Release 2001, 73 (2-3) 401-16
44. Needham, D.; McIntosh, T. J.; Lasic, D. D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes Biochim. Biophys. Acta 1992, 1108 (1) 40-8
45. Torchilin, V. P.; Omelyanenko, V. G.; Papisov, M. I.; Bogdanov, A. A., Jr.; Trubetskoy, V. S.; Herron, J. N.; Gentry, C. A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity Biochim. Biophys. Acta 1994, 1195 (1) 11-20
46. Merdan, T.; Kunath, K.; Petersen, H.; Bakowsky, U.; Voigt, K. H.; Kopecek, J.; Kissel, T. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice Bioconjugate Chem. 2005, 16 (4) 785-92
47. Petersen, H.; Fechner, P. M.; Martin, A. L.; Kunath, K.; Stolnik, S.; Roberts, C. J.; Fischer, D.; Davies, M. C.; Kissel, T. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system Bioconjugate Chem. 2002, 13 (4) 845-54
48. Liu, J.; Jiang, X.; Xu, L.; Wang, X.; Hennink, W. E.; Zhuo, R. Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery Bioconjugate Chem. 2010, 21 (10) 1827-35
49. Yu, Z. Q.; Yan, J. J.; You, Y. Z.; Zhou, Q. H. Bioreducible and acid-labile poly(amido amine)s for efficient gene delivery Int. J. Nanomed. 2012, 7, 5819-32
50. Jere, D.; Jiang, H. L.; Arote, R.; Kim, Y. K.; Choi, Y. J.; Cho, M. H.; Akaike, T.; Cho, C. S. Degradable polyethylenimines as DNA and small interfering RNA carriers Expert Opin. Drug Delivery 2009, 6 (8) 827-34
51. Teo, P. Y.; Yang, C.; Hedrick, J. L.; Engler, A. C.; Coady, D. J.; Ghaem-Maghami, S.; George, A. J.; Yang, Y. Y. Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection Biomaterials 2013, 34 (32) 7971-9
52. Schroeder, A.; Dahlman, J. E.; Sahay, G.; Love, K. T.; Jiang, S.; Eltoukhy, A. A.; Levins, C. G.; Wang, Y.; Anderson, D. G. Alkane-modified short polyethyleneimine for siRNA delivery J. Controlled Release 2012, 160 (2) 172-6
53. Aliabadi, H. M.; Landry, B.; Bahadur, R. K.; Neamnark, A.; Suwantong, O.; Uludag, H. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers Macromol. Biosci. 2011, 11 (5) 662-72
54. Navarro, G.; Essex, S.; Sawant, R. R.; Biswas, S.; Nagesha, D.; Sridhar, S.; de Ilarduya, I. C. T.; Torchilin, V. P. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components Nanomedicine 2014, 10 (2) 411-9
55. Sawant, R. R.; Sriraman, S. K.; Navarro, G.; Biswas, S.; Dalvi, R. A.; Torchilin, V. P. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery Biomaterials 2012, 33 (15) 3942-51
56. Bieber, T.; Elsasser, H. P. Preparation of a low molecular weight polyethylenimine for efficient cell transfection BioTechniques 2001, 30 (1), 74-7, 80-1.
57. Dunlap, D. D.; Maggi, A.; Soria, M. R.; Monaco, L. Nanoscopic structure of DNA condensed for gene delivery Nucleic Acids Res. 1997, 25 (15) 3095-101
58. Werth, S.; Urban-Klein, B.; Dai, L.; Hobel, S.; Grzelinski, M.; Bakowsky, U.; Czubayko, F.; Aigner, A. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes J. Controlled Release 2006, 112 (2) 257-70
59. Ballarin-Gonzalez, B.; Howard, K. A. Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions Adv. Drug Delivery Rev. 2012, 64 (15) 1717-29
60. Wang, Y. Q.; Su, J.; Wu, F.; Lu, P.; Yuan, L. F.; Yuan, W. E.; Sheng, J.; Jin, T. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery Int. J. Nanomed. 2012, 7, 693-704
61. Zheng, M.; Zhong, Y.; Meng, F.; Peng, R.; Zhong, Z. Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection Mol. Pharmaceutics 2011, 8 (6) 2434-43
62. Kircheis, R.; Schuller, S.; Brunner, S.; Ogris, M.; Heider, K. H.; Zauner, W.; Wagner, E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo J. Gene Med. 1999, 1 (2) 111-20
63. Kwoh, D. Y.; Coffin, C. C.; Lollo, C. P.; Jovenal, J.; Banaszczyk, M. G.; Mullen, P.; Phillips, A.; Amini, A.; Fabrycki, J.; Bartholomew, R. M.; Brostoff, S. W.; Carlo, D. J. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver Biochim. Biophys. Acta 1999, 1444 (2) 171-90
64. Ramsay, E.; Gumbleton, M. Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency J. Drug Targeting 2002, 10 (1) 1-9
65. Ramsay, E.; Hadgraft, J.; Birchall, J.; Gumbleton, M. Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro Int. J. Pharm. 2000, 210 (1-2) 97-107
66. Ward, C. M.; Read, M. L.; Seymour, L. W. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy Blood 2001, 97 (8) 2221-9
67. Wolfert, M. A.; Seymour, L. W. Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA Gene Ther. 1996, 3 (3) 269-73
68. Bielinska, A. U.; Chen, C.; Johnson, J.; Baker, J. R., Jr. DNA complexing with polyamidoamine dendrimers: implications for transfection Bioconjugate Chem. 1999, 10 (5) 843-50
69. Chen, D.; Li, N.; Gu, H.; Xia, X.; Xu, Q.; Ge, J.; Lu, J.; Li, Y. A novel degradable polymeric carrier for selective release and imaging of magnetic nanoparticles Chem. Commun. (Cambridge) 2010, 46 (36) 6708-10
70. Haensler, J.; Szoka, F. C., Jr. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture Bioconjugate Chem. 1993, 4 (5) 372-9
71. Roberts, J. C.; Bhalgat, M. K.; Zera, R. T. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers J. Biomed. Mater. Res. 1996, 30 (1) 53-65
72. Schilrreff, P.; Mundina-Weilenmann, C.; Romero, E. L.; Morilla, M. J. Selective cytotoxicity of PAMAM G5 core - PAMAM G2.5 shell tecto-dendrimers on melanoma cells Int. J. Nanomed. 2012, 7, 4121-33
73. Huang, M.; Khor, E.; Lim, L. Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation Pharm. Res. 2004, 21 (2) 344-53
74. Huang, M.; Fong, C. W.; Khor, E.; Lim, L. Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation J. Controlled Release 2005, 106 (3) 391-406
75. Kiang, T.; Wen, J.; Lim, H. W.; Leong, K. W. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection Biomaterials 2004, 25 (22) 5293-301
76. Lavertu, M.; Methot, S.; Tran-Khanh, N.; Buschmann, M. D. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation Biomaterials 2006, 27 (27) 4815-24
77. Xu, Q.; Wang, C. H.; Pack, D. W. Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers Curr. Pharm. Des. 2010, 16 (21) 2350-68
78. Kean, T.; Thanou, M. Biodegradation, biodistribution and toxicity of chitosan Adv. Drug Delivery Rev. 2010, 62 (1) 3-11
79. Bronich, T.; Kabanov, A. V.; Marky, L. A. A thermodynamic characterization of the interaction of a cationic copolymer with DNA J. Phys. Chem. B 2001, 105, 6042-6050
80. Minsky, A.; Ghirlando, R.; Gershon, H., Structural features of DNA-cationic liposomes complexes and their implication for transfection. In Handbook of nonmedical applications of liposomes. From gene delivery and Daignostics to Ecology; Barenholz, Y.; Lasic, D. D., Eds.; CRC Press: 1996; Vol. IV, pp 7-30.
81. Ping, S. Y.; Xu, Q.; Bayer, E. A.; Qian, X.; Rumbles, G.; Himmel, M. E., Bacterial protein complexes applications in nanotecnology In Microbial bionanotechnology: biological self-assembly systems and biopolymers-based nanostructures, Rehm, B. H. A., Ed.; Horizon Bioscience: Great Britain, 2006.
82. Ghirlando, R.; Wachtel, E. J.; Arad, T.; Minsky, A. DNA packaging induced by micellar aggregates: a novel in vitro DNA condensation system Biochemistry 1992, 31 (31) 7110-9
83. Dias, R. S.; Magno, L. M.; Valente, A. J.; Das, D.; Das, P. K.; Maiti, S.; Miguel, M. G.; Lindman, B. Interaction between DNA and cationic surfactants: effect of DNA conformation and surfactant headgroup J. Phys. Chem. B 2008, 112 (46) 14446-52
84. Oskuee, R. K.; Philipp, A.; Dehshahri, A.; Wagner, E.; Ramezani, M. The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery J. Gene Med. 2010, 12 (9) 729-38
85. Merkel, O. M.; Librizzi, D.; Pfestroff, A.; Schurrat, T.; Buyens, K.; Sanders, N. N.; De Smedt, S. C.; Behe, M.; Kissel, T. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging J. Controlled Release 2009, 138 (2) 148-59
86. Navarro, G.; Maiwald, G.; Haase, R.; Rogach, A. L.; Wagner, E.; de Ilarduya, C. T.; Ogris, M. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery J. Controlled Release 2010, 146 (1) 99-105
87. Han, S.; Mahato, R. I.; Kim, S. W. Water-soluble lipopolymer for gene delivery Bioconjugate Chem. 2001, 12 (3) 337-45
88. Wang, D. A.; Narang, A. S.; Kotb, M.; Gaber, A. O.; Miller, D. D.; Kim, S. W.; Mahato, R. I. Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery Biomacromolecules 2002, 3 (6) 1197-207
89. Dewa, T.; Ieda, Y.; Morita, K.; Wang, L.; MacDonald, R. C.; Iida, K.; Yamashita, K.; Oku, N.; Nango, M. Novel polyamine-dialkyl phosphate conjugates for gene carriers. Facile synthetic route via an unprecedented dialkyl phosphate Bioconjugate Chem. 2004, 15 (4) 824-30
90. Dewa, T.; Asai, T.; Tsunoda, Y.; Kato, K.; Baba, D.; Uchida, M.; Sumino, A.; Niwata, K.; Umemoto, T.; Iida, K.; Oku, N.; Nango, M. Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers: chemical structure, morphology, and gene transfer activity Bioconjugate Chem. 2010, 21 (5) 844-52
91. Alshamsan, A.; Haddadi, A.; Incani, V.; Samuel, J.; Lavasanifar, A.; Uludag, H. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine Mol. Pharmaceutics 2009, 6 (1) 121-33
92. Neamnark, A.; Suwantong, O.; Bahadur, R. K.; Hsu, C. Y.; Supaphol, P.; Uludag, H. Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression Mol. Pharmaceutics 2009, 6 (6) 1798-815
93. Bahadur, K. C.; Landry, B.; Aliabadi, H. M.; Lavasanifar, A.; Uludag, H. Lipid substitution on low molecular weight (0.6-2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression Acta Biomater. 2011, 7 (5) 2209-17
94. Sun, C.; Tang, T.; Uludag, H. A molecular dynamics simulation study on the effect of lipid substitution on polyethylenimine mediated siRNA complexation Biomaterials 2013, 34 (11) 2822-33
95. Navarro, G.; Sawant, R. R.; Biswas, S.; Essex, S.; Tros de Ilarduya, C.; Torchilin, V. P. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells Nanomedicine (London) 2012, 7 (1) 65-78
96. Navarro, G.; Sawant, R. R.; Essex, S.; Tros de Ilarduya, C.; Torchilin, V. P. Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery Drug Delivery Transl. Res. 2011, 1 (1) 25-33
97. Ko, Y. T.; Kale, A.; Hartner, W. C.; Papahadjopoulos-Sternberg, B.; Torchilin, V. P. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery J. Controlled Release 2009, 133 (2) 132-8
98. Navarro, G.; Sawant, R. R.; Essex, S.; Tros de Ilarduya, C.; Torchilin, V. P. Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery Drug Delivery Transl. Res. 2011, 1 (1) 25-33
99. Essex, S.; Navarro, G.; Sabhachandani, P.; Chordia, A.; Trivedi, M.; Movassaghian, S.; Torchilin, V. P. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors Gene Ther. 2014, 10.1038/gt.2014.97
100. Lukyanov, A. N.; Torchilin, V. P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs Adv. Drug Delivery Rev. 2004, 56 (9) 1273-89
101. Bielinska, A.; Kukowska-Latallo, J. F.; Johnson, J.; Tomalia, D. A.; Baker, J. R., Jr. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers Nucleic Acids Res. 1996, 24 (11) 2176-82
102. Kukowska-Latallo, J. F.; Bielinska, A. U.; Johnson, J.; Spindler, R.; Tomalia, D. A.; Baker, J. R., Jr. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (10) 4897-902
103. Rajananthanan, P.; Attard, G. S.; Sheikh, N. A.; Morrow, W. J. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses Vaccine 1999, 17 (7-8) 715-30
104. Boas, U.; Heegaard, P. M. Dendrimers in drug research Chem. Soc. Rev. 2004, 33 (1) 43-63
105. Kim, J. Y.; Ryu, J. H.; Hyun, H.; Kim, H. A.; Choi, J. S.; Yun Lee, D.; Rhim, T.; Park, J. H.; Lee, M. Dexamethasone conjugation to polyamidoamine dendrimers G1 and G2 for enhanced transfection efficiency with an anti-inflammatory effect J. Drug Targeting 2012, 20 (8) 667-77
106. Khopade, A. J.; Shenoy, D. B.; Khopade, S. A.; Jain, N. K. Phase structures of a hydrated anionic phospholipid composition containing cationic dendrimers and pegylated lipids Langmuir 2004, 20 (18) 7368-73
107. Movassaghian, S.; Moghimi, H. R.; Shirazi, F. H.; Torchilin, V. P. Dendrosome-dendriplex inside liposomes: as a gene delivery system J. Drug Targeting 2011, 19 (10) 925-32
108. Takahashi, T.; Kono, K.; Itoh, T.; Emi, N.; Takagishi, T. Synthesis of novel cationic lipids having polyamidoamine dendrons and their transfection activity Bioconjugate Chem. 2003, 14 (4) 764-73
109. Takahashi, T.; Kojima, C.; Harada, A.; Kono, K. Alkyl chain moieties of polyamidoamine dendron-bearing lipids influence their function as a nonviral gene vector Bioconjugate Chem. 2007, 18 (4) 1349-54
110. Kono, K.; Ikeda, R.; Tsukamoto, K.; Yuba, E.; Kojima, C.; Harada, A. Polyamidoamine dendron-bearing lipids as a nonviral vector: influence of dendron generation Bioconjugate Chem. 2012, 23 (4) 871-9
111. Yuba, E.; Nakajima, Y.; Tsukamoto, K.; Iwashita, S.; Kojima, C.; Harada, A.; Kono, K. Effect of unsaturated alkyl chains on transfection activity of poly(amidoamine) dendron-bearing lipids J. Controlled Release 2012, 160 (3) 552-60
112. Zhou, X. H.; Klibanov, A. L.; Huang, L. Lipophilic polylysines mediate efficient DNA transfection in mammalian cells Biochim. Biophys. Acta 1991, 1065 (1) 8-14
113. Liu, X.; Zhou, J.; Yu, T.; Chen, C.; Cheng, Q.; Sengupta, K.; Huang, Y.; Li, H.; Liu, C.; Wang, Y.; Posocco, P.; Wang, M.; Cui, Q.; Giorgio, S.; Fermeglia, M.; Qu, F.; Pricl, S.; Shi, Y.; Liang, Z.; Rocchi, P.; Rossi, J. J.; Peng, L. Adaptive Amphiphilic Dendrimer-Based Nanoassemblies as Robust and Versatile siRNA Delivery Systems Angew. Chem., Int. Ed. 2014, 53 (44) 11822-7
114. Park, J. U.; Ishihara, T.; Kano, A.; Akaike, T.; Maruyama, A. Preparation of dendritic graft copolymer consisting of poly-(L-lysine) and arabinogalactan as a hepatocyte specific DNA carrier Prep. Biochem. Biotechnol. 1999, 29 (4) 353-70
115. Wu, G. Y.; Wu, C. H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system J. Biol. Chem. 1987, 262 (10) 4429-32
116. Laemmli, U. K. Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine Proc. Natl. Acad. Sci. U.S.A. 1975, 72 (11) 4288-92
117. Ziady, A. G.; Ferkol, T.; Dawson, D. V.; Perlmutter, D. H.; Davis, P. B. Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo J. Biol. Chem. 1999, 274 (8) 4908-16
118. Kwoh, D. Y.; Coffin, C. C.; Lollo, C. P.; Jovenal, J.; Banaszczyk, M. G.; Mullen, P.; Phillips, A.; Amini, A.; Fabrycki, J.; Bartholomew, R. M.; Brostoff, S. W.; Carlo, D. J. Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver Biochim. Biophys. Acta, Gene Struct. Expression 1999, 1444 (2) 171-190
119. Männistö, M.; Vanderkerken, S.; Toncheva, V.; Elomaa, M.; Ruponen, M.; Schacht, E.; Urtti, A. Structure-activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery J. Controlled Release 2002, 83 (1) 169-182
120. Choi, Y. H.; Liu, F.; Kim, J. S.; Choi, Y. K.; Park, J. S.; Kim, S. W. Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier J. Controlled Release 1998, 54 (1) 39-48
121. Wagner, E.; Ogris, M.; Zauner, W. Polylysine-based transfection systems utilizing receptor-mediated delivery Adv. Drug Delivery Rev. 1998, 30 (1-3) 97-113
122. Plank, C.; Mechtler, K.; Szoka, F. C., Jr.; Wagner, E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery Hum. Gene Ther. 1996, 7 (12) 1437-46
123. Jeong, J. H.; Park, T. G. Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers J. Controlled Release 2002, 82 (1) 159-66
124. Blum, J. S.; Saltzman, W. M. High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine J. Controlled Release 2008, 129 (1) 66-72
125. Incani, V.; Lin, X.; Lavasanifar, A.; Uludag, H. Relationship between the extent of lipid substitution on poly(L-lysine) and the DNA delivery efficiency ACS Appl. Mater. Interfaces 2009, 1 (4) 841-8
126. Abbasi, M.; Uludag, H.; Incani, V.; Hsu, C. Y.; Jeffery, A. Further investigation of lipid-substituted poly(L-Lysine) polymers for transfection of human skin fibroblasts Biomacromolecules 2008, 9 (6) 1618-30
127. Prabaharan, M. Review paper: chitosan derivatives as promising materials for controlled drug delivery J. Biomater. Appl. 2008, 23 (1) 5-36
128. Mumper, R. J.; W, J.; Claspell, J. M.; Rolland, A. P. Novel polymeric condensing carriers for gene delivery Proc. Int. Symp. Controlled Release Bioact. Mater. 1995, 22, 178-179
129. Katas, H.; Alpar, H. O. Development and characterisation of chitosan nanoparticles for siRNA delivery J. Controlled Release 2006, 115 (2) 216-25
130. Howard, K. A.; Rahbek, U. L.; Liu, X.; Damgaard, C. K.; Glud, S. Z.; Andersen, M. O.; Hovgaard, M. B.; Schmitz, A.; Nyengaard, J. R.; Besenbacher, F.; Kjems, J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system Mol. Ther. 2006, 14 (4) 476-84
131. Techaarpornkul, S.; Wongkupasert, S.; Opanasopit, P.; Apirakaramwong, A.; Nunthanid, J.; Ruktanonchai, U. Chitosan-Mediated siRNA Delivery In Vitro: Effect of Polymer Molecular Weight, Concentration and Salt Forms AAPS PharmSciTech 2010, 11 (1) 64-72
132. Jean, M.; Alameh, M.; De Jesus, D.; Thibault, M.; Lavertu, M.; Darras, V.; Nelea, M.; Buschmann, M. D.; Merzouki, A. Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes Eur. J. Pharm. Sci. 2012, 45 (1-2) 138-49
133. Du, Y. Z.; Lu, P.; Zhou, J. P.; Yuan, H.; Hu, F. Q. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation Int. J. Pharm. 2010, 391 (1-2) 260-6
134. Chae, S. Y.; Son, S.; Lee, M.; Jang, M. K.; Nah, J. W. Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier J. Controlled Release 2005, 109 (1-3) 330-44
135. Kabanov, A. V.; Kabanov, V. A. DNA Complexes with Polycations for the Delivery of Genetic Material into Cells Bioconjugate Chem. 1995, 6 (1) 7-20
136. Mandke, R.; Singh, J. Effect of acyl chain length and unsaturation on physicochemical properties and transfection efficiency of N-acyl-substituted low-molecular-weight chitosan J. Pharm. Sci. 2012, 101 (1) 268-82
137. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 2009, 8 (7) 543-57
138. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (7) 2050-5
139. Sarisozen, C.; Vural, I.; Levchenko, T.; Hincal, A. A.; Torchilin, V. P. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance Drug Delivery 2012, 19 (8) 363-70
140. Elbayoumi, T. A.; Torchilin, V. P. Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice Mol. Pharmaceutics 2009, 6 (1) 246-54
141. Lukyanov, A. N.; Sawant, R. M.; Hartner, W. C.; Torchilin, V. P. PEGylated dextran as long-circulating pharmaceutical carrier J. Biomater. Sci., Polym. Ed. 2004, 15 (5) 621-30
142. Weissig, V. V.; Babich, J.; Torchilin, V. V. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool Colloids Surf., B 2000, 18 (3-4) 293-9
143. Torchilin, V. Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Delivery Rev. 2011, 63 (3) 131-5
144. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46 (12 Part 1) 6387-92
145. Endres, T. K.; Beck-Broichsitter, M.; Samsonova, O.; Renette, T.; Kissel, T. H. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery Biomaterials 2011, 32 (30) 7721-31
146. Endres, T.; Zheng, M.; Kilic, A.; Turowska, A.; Beck-Broichsitter, M.; Renz, H.; Merkel, O. M.; Kissel, T. Amphiphilic biodegradable PEG-PCL-PEI triblock copolymers for FRET-capable in vitro and in vivo delivery of siRNA and quantum dots Mol. Pharmaceutics 2014, 11 (4) 1273-81
147. Wang, T.; Upponi, J. R.; Torchilin, V. P. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies Int. J. Pharm. 2012, 427 (1) 3-20
148. Kim, H. J.; Miyata, K.; Nomoto, T.; Zheng, M.; Kim, A.; Liu, X.; Cabral, H.; Christie, R. J.; Nishiyama, N.; Kataoka, K. siRNA delivery from triblock copolymer micelles with spatially-ordered compartments of PEG shell, siRNA-loaded intermediate layer, and hydrophobic core Biomaterials 2014, 35 (15) 4548-56
149. Biswas, S.; Deshpande, P. P.; Navarro, G.; Dodwadkar, N. S.; Torchilin, V. P. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery Biomaterials 2013, 34 (4) 1289-301
150. Mao, C. Q.; Du, J. Z.; Sun, T. M.; Yao, Y. D.; Zhang, P. Z.; Song, E. W.; Wang, J. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy Biomaterials 2011, 32 (11) 3124-33
151. Sun, T. M.; Du, J. Z.; Yan, L. F.; Mao, H. Q.; Wang, J. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery Biomaterials 2008, 29 (32) 4348-55
152. Sun, T. M.; Du, J. Z.; Yao, Y. D.; Mao, C. Q.; Dou, S.; Huang, S. Y.; Zhang, P. Z.; Leong, K. W.; Song, E. W.; Wang, J. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression ACS Nano 2011, 5 (2) 1483-94
153. Wang, H. X.; Xiong, M. H.; Wang, Y. C.; Zhu, J.; Wang, J. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver J. Controlled Release 2013, 166 (2) 106-14
154. Liu, X. Q.; Xiong, M. H.; Shu, X. T.; Tang, R. Z.; Wang, J. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth Mol. Pharmaceutics 2012, 9 (10) 2863-74
155. Zhu, L.; Torchilin, V. P. Stimulus-responsive nanopreparations for tumor targeting Integr. Biol. (Cambridge) 2013, 5 (1) 96-107
156. Lee, E. S.; Gao, Z.; Bae, Y. H. Recent progress in tumor pH targeting nanotechnology J. Controlled Release 2008, 132 (3) 164-70
157. Xiong, X. B.; Lavasanifar, A. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin ACS Nano 2011, 5 (6) 5202-13
158. Zhu, L.; Wang, T.; Perche, F.; Taigind, A.; Torchilin, V. P. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (42) 17047-52
159. Zhu, L.; Perche, F.; Wang, T.; Torchilin, V. P. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs Biomaterials 2014, 35 (13) 4213-22